News

Fierce Pharma20m
Daiichi Sankyo, AstraZeneca's highly touted ADC Datroway off to 'smooth market launch'
But so far, so good for the TROP2-directed treatment, which is off to a "smooth market launch,” according to Daiichi CEO ...
The Star20mOpinion
EDGAR ODARI: Kenya-UAE deal will make some medicines very expensive
Kenya faces a significant disease burden that costs the country a lot of money. According to the National Aids and STIs ...